Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
Crossref DOI link: https://doi.org/10.1007/s13402-014-0210-8
Published Online: 2015-01-09
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maier, Armin
Peille, Anne-Lise
Vuaroqueaux, Vincent
Lahn, Michael
License valid from 2015-01-09